Intraoperative Cerebral Glioma Characterization with Contrast Enhanced Ultrasound

Francesco Prada(Fondazione IRCCS Istituto Neurologico Carlo Besta), Luca Mattei(University of Milan), Massimiliano Del Bene(Fondazione IRCCS Istituto Neurologico Carlo Besta), Luca Aiani(Ospedale Valduce), Marco Saini(Fondazione IRCCS Istituto Neurologico Carlo Besta), Cecilia Casali(Fondazione IRCCS Istituto Neurologico Carlo Besta), Assunta Filippini(University of Milan), Federico Legnani(Fondazione IRCCS Istituto Neurologico Carlo Besta), Alessandro Perin(Fondazione IRCCS Istituto Neurologico Carlo Besta), Andrea Saladino(Fondazione IRCCS Istituto Neurologico Carlo Besta), Ignazio G. Vetrano(University of Milan), Luigi Solbiati(Ospedale di Circolo di Busto Arsizio), Alberto Martegani(Ospedale Valduce), Francesco DiMeco(Johns Hopkins University)
BioMed Research International
January 1, 2014
Cited by 96Open Access
Full Text

Abstract

BACKGROUND: Contrast enhanced ultrasound (CEUS) is a dynamic and continuous modality providing real-time view of vascularization and flow distribution patterns of different organs and tumors. Nevertheless its intraoperative use for brain tumors visualization has been performed few times, and a thorough characterization of cerebral glioma had never been performed before. AIM: To perform the first characterization of cerebral glioma using CEUS and to possibly achieve an intraoperative differentiation of different gliomas. METHODS: We performed CEUS in an off-label setting in 69 patients undergoing surgery for cerebral glioma. An intraoperative qualitative analysis was performed comparing iCEUS with B-mode imaging. A postprocedural semiquantitative analysis was then performed for each case, according to EFSUMB criteria. Results were related to histopathology. RESULTS: We observed different CE patterns: LGG show a mild, dotted CE with diffuse appearance and slower, delayed arterial and venous phase. HGG have a high CE with a more nodular, nonhomogeneous appearance and fast perfusion patterns. CONCLUSION: Our study characterizes for the first time human brain glioma with CEUS, providing further insight regarding these tumors' biology. CEUS is a fast, safe, dynamic, real-time, and economic tool that might be helpful during surgery in differentiating malignant and benign gliomas and refining surgical strategy.


Related Papers